• Corpus ID: 211010888

# GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker

@article{Kasanda2020GEANT4SO,
title={GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker},
author={Eva Kasanda and C Burbadge and Vinzenz Bildstein and J. Turko and Artemis Spyrou and Cornelia Hohr and D. Mucher},
journal={arXiv: Medical Physics},
year={2020}
}
• Published 3 February 2020
• Physics
• arXiv: Medical Physics
In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic $\gamma$ rays…

## References

SHOWING 1-10 OF 39 REFERENCES

• Physics
Physics in medicine and biology
• 2014
Results show that quantitative prompt gamma-ray measurements enable knowledge of nuclear reaction cross sections to be used for precise proton range verification in the presence of tissue with an unknown composition.
• Physics, Medicine
Front. Oncol.
• 2016
The first tests of the timing method at a clinical proton accelerator are summarized, its applicability in a clinical environment for challenging the current safety margins is assessed, and the factors limiting its precision are discussed.
• Physics, Medicine
Physics in medicine and biology
• 2018
3D PG imaging for proton range verification under clinical beam delivery conditions is possible with a single Compton camera, and shifts in the proton beam range as small as 2 mm could be detected for delivery of a 2 Gy spot.
• Physics
International journal of radiation oncology, biology, physics
• 1977
• Medicine, Physics
IEEE Transactions on Nuclear Science
• 2005
The clinical feasibility of in-beam PET for proton therapy monitoring is strongly supported and the possible extraction of valuable clinical information as particle range in-vivo, irradiation field position, and even local deviations from the dose prescription on the basis of the comparison between measured and predicted activity distributions is indicated.
• Medicine
Medical physics
• 2018
This contribution critically reviews methods under development or clinical testing for verification of ion therapy, based on pretreatment range and tissue probing as well as the detection of secondary emissions or physiological changes during and after treatment, to disentangle approaches of general applicability from those more specific to certain anatomical locations.
• H. Paganetti
• Physics, Medicine
Physics in medicine and biology
• 2012
A significant impact of Monte Carlo dose calculation can be expected in complex geometries where local range uncertainties due to multiple Coulomb scattering will reduce the accuracy of analytical algorithms and in these cases Monte Carlo techniques might reduce the range uncertainty by several mm.
• Medicine, Physics
Physics in medicine and biology
• 2013
In this review, state-of-the art in vivo proton range verification methods currently being proposed, developed or clinically implemented are described and compared.
• Medicine, Physics